In gastrointestinal tract cancers, targeting enzymatic activity of Nampt/PBEF/visfatin has inhibited proliferation, migration, and anchorage-independent growth [16, 17] and induced apoptosis [16–19], implying Nampt/PBEF/visfatin involvement in proliferation, migration, and survival of cancer cells. Here, NAMPT is linked to cancer.